chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A couple of weeks after taking the vaccine, I suffered from a break through case of COVID-19. The first weeks it just felt like a cold that went away for a few days and then came back stronger. I took an at home test and came back positive. I suffered from fuzzy head, body aches, headaches, very tired, and a cough that hurt. I spoke to my doctor and gave me Paxlovid. I felt better within a few days but then started having chest problems. I did a remote urgent care and they told me to go to the ER because they were concerned with chest pain. I went into the clinic instead because I did not have heart attack symptoms that I feared going to the ER. They did an EKG and vitals and everything looked good. I had really abnormal GI symptoms. I had no appetite, a metallic taste, and was very bloated. I am still suffering from sore throat symptoms and my voice is raspy, and I still have upper congestion and it all manifests during the evening and I wake up with a cough everyday however it gets slightly better as the day progresses.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapy were not reported. On unknown dates, the patient was vaccinated with the first and second dose of VAQTA (dose, route of administration, lot number and expiration date were not reported). On an unknown date, the patient was inadvertently vaccinated in the left deltoid with the third dose of VAQTA (dose, route of administration, lot number reported as M003618 and expiration date 18-NOV-2017) instead of an intended dose of RECOMBIVAX HB. When the error was noticed, the patient was vaccinated in the right deltoid with RECOMBIVAX HB (lot number L038499 and expiration date 26-JUN-2017, dose and route of administration were not reported) on the same date as well. The reporter stated that there was no confusion on the labeling but that both products were in the same container, and the reporter just picked the wrong one. No adverse effect was reported. Additional information has been requested.
Skin- warm red and raised around the injection site. Redness measured 80 X 70 mm.
Patient had a fever and chills for about 1.5 days following the vaccine.  She developed a severe headache the day after getting the vaccine.  The headache has been present every day since she received the vaccine and she also has intermittent neck pain.
LT SIDE OF HEAD STARTED HURTING, SOME THROBBING IN LT EAR. THEN LATER IN DAY VISION TO LT EYE BECAME DIM. WENT TO A CLINIC. DR SENT ME TO A RETINAL SPECIALIST, THEN THAT DR SENT ME TO A NEUROLOGIST WHO SPECIALIZES IN MULTIPLE SCLEROSIS. HE TOLD ME I HAD OPTIC NEURITIS. HAD TO BE TREATED WITH 5 DAYS OF IV MEDS. THEN WORKED ME UP FOR MS. I AM STILL BEING TREATED BY THOSE DOCTORS TO THIS DAY. THEY ALSO SENT ME TO A IMMUNOLOGISTS BECAUSE I NOW NEED IGG. I HAVE NO HX OF ANY ILLNESSES NOR DOES MY FAMILY. I AM A REGISTERED NURSE. THIS PROBLEM (POOR VISION) NEUROPATHY AROUND MY LEFT EYE THE CHANCE OF A RELAPSE, THE MONEY IT HAS COST ME, HAS BEEN FINANCIALLY AND EMOTIONALLY DRAINING NOT TO MENTION THE FACT THAT I NOW HAVE TO HAVE THE SCAR OF BEING TAGGED AS A "OPTIC NEURITIS" PATIENT
Information has been received from a physician concerning a patient with a history of gastroschisis who was vaccinated po with the first and second doses of ROTATEQ (dates unspecified). It was reported that the patient was "gagging" on the second dose of ROTATEQ and full dose was not given to patient. The outcome was not reported. A product quality complaint was not involved. Additional information has been requested.
I got one shot in my left arm on the 24th of March.  On the 26th of March I had pain in my left arm that went into my left side of my neck and head (for approximately  4 hours).  This was moderate.  I took Tylenol.  The next day on the 27th I began to feel like I had a cold.  On the 28th I started getting "flu like" symptoms.   I was healthy and doing well prior to shot of Janssen.  Better than I have been in a year. Then 3rd day after shot I began to have congestion and runny nose.  Then low fever.  4th day I was very congested, dizzy and had a bad headache so went to urgent care. I was prescribed Norco for the headache and sent home.  I could not sleep or eat and became sicker.  My sinuses began to swell, and my ears hurt badly.  My head was pounding and swelling in the frontal lobes.  By the 6th day I could not see well.  My vision had doubled, my eyes had so much pressure and my chest were hurting.  I went to the Emergency Room at AV Hospital by car.  I was seen and given a virus test that was negative.  I was sent home and told to take the Norco for the headache.  The 7th night I could not see, I was seeing 4 of everything.  My head hurt more than I ever have experienced.  I had difficulty breathing and had chest pains.  I was weak and dizzy.  We called the ambulance that took me to AV Hospital.  They did a CT scan and said I had a severe sinus infection prescribed antibiotics and sent me home to take Norco and antibiotics.  I woke the following morning with the inability to swallow, my throat severely swollen like a rock, my head swollen twice it?s size, my sinuses completely clogged, trouble breathing, my head severely in pain and fear I was dying.  My daughter had called the advice nurse who said go to the ER immediately.  This time I went to Palmdale Regional.  After several tests and 11 hours of waiting in their lobby I was taken into the ER to a room.  A MRI was done and I was told they had found ?bleeding? in my brain.   I would later be told I had a stroke.  I was admitted to the hospital to their stroke center immediately for treatment. I remained in the hospital for 5 days. I was blind for several weeks as my eyes had obtained so much pressure from the stroke. Prior to the Johnson shot I was regaining good health at a rapid pace.  I had been sick for several years but that had turned around and my physical condition was strong and healthy.  After the shot I became very weak, close to death and it has taken from April until end of July for me to start feeling good enough to work.  I continue to have problems with my eyes and difficulty with my sinuses with congestion when I wake.  This condition did not exist until after the shot of the vaccine.  I am self employed as a Clinical Social Worker and did not have any unemployment to sustain my income during this time I have been sick or sick leave.
30OCT93 pain & induration deltoid extending into shoulder area on lt; no fever; pain & swelling inc through out day; 31OCT93 adenopathy area noted with red streak; entire neck itching, then stiff neck;
Child recieved 4 immunizations at 1125. At 1140 mother yelled for help stating that the child went limp and sat down on her leg with a 5 second loss of consciousness. Mother denied child hitting his head. Child was assisted to a sitting position on the floor by staff members. Child threw up 15-30 cc of yellow stomach contents. Child was assisted to lie down on floor, feet elevtaed and an ice pack was placed on back of his neck. Vitals were taken at 1140, blood pressure was 92/56 in left arm, pulse 64, respirations were 16. No further loss of consciousness noted. Blood pressure taken at 1150 in right arm was 98/56. Child got off floor and sat in chair until 1200 and left building with mother and family friend.
Office Visit 4/30  Suspected COVID-19 virus infection +2 more Dx Fever  ? Cough  ? Sore Throat ? Dizziness ? Headache  Reason for Visit ED to Hosp-Admission Discharged  5/1/2021 - 5/5/2021 (4 days)   Last attending ? Treatment team COVID-19 Principal problem Discharge Summary        INPATIENT DISCHARGE SUMMARY  .                                                            Date: 5/5/2021         Length of stay: 4 Days     Admission diagnosis:     Primary Admission Diagnosis    Medical Problems     Hospital Problems        POA    * (Principal) COVID-19 Yes              Hospital Course   HPI: 65-year-old man admitted with COVID-19 pneumonia     Hospital Course: This man was admitted with COVID-19 pneumonia.  He had a possible bacterial superinfection.  His procalcitonin was elevated.  We therefore treated him with antibiotics for the bacterial superinfection, and treated him with convalescent plasma, remdesivir, and dexamethasone for his Covid infection.  Patient is doing much better now.  He is breathing well on room air and feels ready to go home.  Physical and Occupational Therapy saw him and they recommended home health at discharge.  We are talking to the patient about whether he prefers to go to a inpatient rehabilitation facility versus home with home health.  That is still up in the air at this moment we will follow whenever pathway is most appropriate.   The patient did have some elevated liver function test on admission but these are better at the time of discharge.  He also has continuous narcotic dependence and is getting frequent opioids.  This is keeping his chronic back pain under control.   On the day of discharge the patient is feeling very good and is eager for discharge.
Caused Thyroid flare up an put me back into Hypothyroid.  Before having blood work done, was feeling dizzy every day, heaviness in head, slow heartbeat, extremely tired.
I was feeling lethargic, and was seeing silver line when i moved my head to the left.  The line stays for 2 days, but disappeared today, 3/4/21
No Adverse Event; Dose administered more than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) and NO ADVERSE EVENT (No Adverse Event) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1417B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jan-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Jan-2023,  after starting , the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture).    No relevant concomitant medications were reported.   The vial was initially stored in the refrigerator on 20-Jan-2023. Date and time vial was first punctured was 20-Jan-2023 at 9:20 am. Date and time of administration of vaccine was 23-Jan-2023 at 12:40-1:00 pm. The vial was stored in fridge post puncture. The vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) was left out an hour to thaw on 20-Jan-2023.  No treatment information was provided.
Patient discovered pox on 1/22 and parent on 1/23.  Taken to doctor on 1/23 and diagnosed as pox.  Site of vaccine was swollen, red, warm to touch.  Gave pt Benadryl, Tylenol to prevent fever, calamine lotion and oatmeal baths.  Today pox have scab over.
started @ 12noon high-pitched persistent crying; returned to office 230 watched for 1 1/2 hrs, irritable but can be comforted;
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2009, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 01-DEC-2015, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
woke up on June 29, 2021, with the worst back pain ever. email the doctor but he was not there this week. Emailed back on 6.30.2021 and still waiting on the doctor to return. The VA sent me to urgent care for help. They gave me a shot for the pain and prednisone for the inflation on the nerve. They said it was the sciatic nerve going the Peroneal nerve. This didn't help.  I contacted the VA on July 2 2021 and they mail out more prednisone. Emailed VA July 7 2021 Told them the perinsone wasn't working and they moved me to tramadol 10mg and lidoderm patches. Contact Va on July8 July 12 July13 still the same
I started to feel very tired. I had pain in all my major joints. It felt like a fibromyalgia flare up. I had trouble sleeping and thinking. By the 4th week in April I could no longer walk I resigned from my job without notice on 4/30/2021. Prior to my resignation, my PA made notes when I spoke with her. I also spoke with my therapist and she advised me should would no longer make notes for me because I was too sick to work.
This spontaneous report as received from a medical assistant refers to 3 patients of unknown age and gender. On an unknown date 3 unspecified patients were vaccinated with VARIVAX (Merck) injection (lot number and expiry date unknown) (dosing regimen and frequency unknown) that was improperly stored. No concomitant medications were reported. No adverse events were reported. The action taken with the therapy with VARIVAX (Merck) was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with VARIVAX (Merck) was unknown. No product quality issue was reported. Additional information has been requested.
hives; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): RA2021US186601_NC (Regulatory Authority).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: URTICARIA (non-serious), outcome "unknown", described as "hives".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
In addition to expected soreness, fatigue, and muscle aches in the two days after the vaccine, I experienced itchy red hives and swelling beginning the morning of November 30th. The hives began on the soles of my feet and continued spreading up my legs the rest of the day. Some small hives also appeared on the backs of my hands that morning. By the morning of December 1st, there were hives all over my body including my face, ears, and the palms of my hands, and my hands, legs/feet, and upper lip were all swollen. Hives and swelling decreased on Thursday, December 2nd, and were almost entirely gone by the afternoon of December 3rd. Red splotches and itching persisted until December 4th, and more itching than is typical continues today. I treated with hydrocortisone cream and other soothing lotions, and I elevated my swollen legs. They eased the symptoms, but only time decreased the presence of the hives and swelling.
THE PATIENT FAINTED AND WAS HAVING JERKING MOVEMENTS APPROXIMATELY 10 SECONDS AFTER GIVING HER THE MENINGOCOCCAL VACCINE. I USED AMMONIA TO BRING HER BACK. SHE WAS EXPERIENCING STOMACH UPSET AND I HAD TO CALL THE RESCUE WHEN THEY ARRIVED ABOUT 20 MIN LATER THE PATIENT BLOOD PRESSURE WAS 50 ALL THE OTHER VITAL SIGNS WERE GOOD. IT TOOK THE PATIENT ABOUT 1 HOUR TO FEEL STRONG ENOUGH TO WALK AND HAVE HER GRAND MOTHER PICK HER UP.
shingles developed in 5 days after the shot. (same as my husband) Went to dr and got  Valacyclovir for 7 days.  Have had recurring shingles since then  Have taken 4 prescriptions and currently taking the 5th prescriptionValacyclovir.  Have shingles on both sides of my body.  Doctor says thats not possible but is happening with each reoccurrence.
G-B Type Syndrome. Acute onset with bilateral paralysis of lower extremities as well as neurogenic bladder.
Receive shot at approximately 3:30pm on November 29, 2019.  About 7:00 pm I couldn't lift my right arm.  Pain, numbness and tingling feeling up and down entire right arm.  Shot given in very upper portion of right shoulder.  As of today, December 10, 2019 I still have pain in right shoulder, some pain in right arm and tingling and some numbness in right hand.  From November 29, 2019 to half day on Sunday, December 1, 2019 couldn't lift my right arm at all without help with the use of my left hand.
shingles and other zoster-related conditions; shingles and other zoster-related conditions; This spontaneous report was received from a lawyer regarding a case in litigation and referred to a patient (pt) of unknown age or gender. No information was provided regarding concomitant medications, concurrent conditions, or medical history. On or about 01-MAR-2014 (at 59 years old), the pt was administered zoster vaccine live (ZOSTAVAX) (strength, dose, frequency, route of administration, lot number and expiration date were not provided) by a healthcare provided (HCP) at a healthcare facility for the long-term prevention of shingles and zoster-related conditions. Subsequently, the pt was treated by an HCP for the following injuries resulting from the pt zoster vaccine live (ZOSTAVAX) use: shingles (herpes zoster) and other zoster-related conditions (ill-defined disorder). Outcome of the event was not provided. Causal relationship of the events was reported as related to zoster vaccine live (ZOSTAVAX).
I received the FluZone vaccine at 17 week pregnant. Ten days after getting the shot I developed flu-like symptoms, including fever, chills and body aches that last for three days. Within two days of developing these symptoms, I started to experience pregnancy complications: bleeding and cramping. I visited the ER twice and each time I was assured that the baby was fine. I had two ultrasounds several days apart. Each scan revealed that the baby, placenta and uterus were fine. Within a week of developing these symptoms I went into pre-term labor. My baby was born at 18 weeks gestation without any known cause. I suspect I developed a reaction to the vaccine.
Itchy red rash on the left arm.  Treated with Benadryl.  Getting a little better.
Shot on 4/16 left arm red circular rash developed 7 days later rash is warm, semi hard, swollen was itching to start.
1452 feeling "thick tongue" flushed tingling lips BP 187/101 HR 94 Benadryl 50mg po provided 1456 BP 146/90 HR 91 RR 20 Sats 98 1500 BP 133/91 HR 86 RR 18 Sats 98
Lightheaded, nausea, vomited four times, and headache; donor advised he felt better eight hours after initial onset of symptoms. No treatment was given since patient did not notify provider and did not seek medical care.
2 months later / only administered the lyophilized powder mixed with normal saline; Inappropriate dose of vaccine administered; received the 1st dose of adjuvant suspension only / 2 months later / only administered the lyophilized powder mixed with normal saline/ HCP mixed the adjuvant portion with saline solution; received the 1st dose of adjuvant suspension only / 2 months later / only administered the lyophilized powder mixed with normal saline; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In April 2021, the patient received the 1st dose of Shingrix. In June 2021, the patient received the 2nd dose of Shingrix. In April 2021, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. In June 2021, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered, wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the 1st dose of adjuvant suspension only, and came back 2 months later and only administered the lyophilized powder mixed with normal saline. No adverse events reported by patient. This was 4 of 9 linked cases reported by same reporter for different patients. The reporter consented to follow up.   Follow up information received from sales representative on 25 June 2021: The reporter stated that, the health care professional mixed the adjuvant portion with saline solution and administrated it as a first dose and later reconstituted the powder portion with saline solution as second dose. The event inappropriate preparation of medication for 1st dose updated to wrong solution used in drug reconstitution as stated that the health care professional mixed the adjuvant portion with saline solution. The reporter did not know exact date, patient's involved and outcome.  No further events were reported. The reporter consented to follow up; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR138546:Same reporter US-GLAXOSMITHKLINE-US2021AMR138553:Same reporter US-GLAXOSMITHKLINE-US2021AMR138552:Same reporter US-GLAXOSMITHKLINE-US2021AMR138555:Same reporter US-GLAXOSMITHKLINE-US2021AMR138556:Same reporter US-GLAXOSMITHKLINE-US2021AMR138557:Same reporter US-GLAXOSMITHKLINE-US2021AMR138558:Same reporter US-GLAXOSMITHKLINE-US2021AMR138559:Same reporter US-GLAXOSMITHKLINE-US2021138628:FU1 Delated
Swelling of the lips; Blood pressure spiked; Half of the face numb; Itching all over; rash all over the body; Metal taste; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Metal taste), LIP SWELLING (Swelling of the lips), HYPERTENSION (Blood pressure spiked), HYPOAESTHESIA (Half of the face numb) and PRURITUS (Itching all over) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart disorder since an unknown date. Concomitant products included CARVEDILOL, AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CLOPIDOGREL, ATORVASTATIN, ENALAPRIL and FISH OIL for an unknown indication, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced DYSGEUSIA (Metal taste). On 27-Feb-2021, the patient experienced LIP SWELLING (Swelling of the lips), HYPERTENSION (Blood pressure spiked), HYPOAESTHESIA (Half of the face numb), PRURITUS (Itching all over) and RASH (rash all over the body). On 26-Feb-2021, DYSGEUSIA (Metal taste) had resolved. On 01-Mar-2021, LIP SWELLING (Swelling of the lips), HYPOAESTHESIA (Half of the face numb) and PRURITUS (Itching all over) had resolved. At the time of the report, HYPERTENSION (Blood pressure spiked) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.